Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (301246.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

20.6x

Market Cap

CNY 8.34B

MomentumView details →

1D Return

−1.28%

YTD Return

−27.08%

RSI (14)

30.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

20.6x

Market Cap

CNY 8.34B

RSI (14)

30.1

MomentumView details →

1D Return

−1.28%

YTD Return

−27.08%

ProfitabilityView details →

Gross Margin

24.10%

Net Margin

11.52%

EBITDA Margin

16.40%

ROE (TTM)

5.52%

ROA (TTM)

4.05%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

+24.26%

EPS YoY

+776.17%

FCF YoY

—

Revenue CAGR 3Y

−2.05%

EPS CAGR 3Y

−37.57%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.11x

Current Ratio

2.88x

Quick Ratio

2.60x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

2.21B

Net Income (TTM)

254.51M

Op. CF (TTM)

−71.87M

Latest newsMore news →

Hongyuan Pharmaceutical reported first-half 2026 net profit of 156 million yuan, turning from a loss in the same period of 2025.10d ago

Similar companies

北摩高科002985.SZ 科陆电子002121.SZ 仙琚制药002332.SZ 千红制药002550.SZ 博苑新材301617.SZ 上大股份301522.SZ

Latest newsMore news →

Hongyuan Pharmaceutical reported first-half 2026 net profit of 156 million yuan, turning from a loss in the same period of 2025.10d ago